SCHEMBL5361287

SCHEMBL5361287

CCN(Cc1cccc(C)c1)C(=O)COc1ccc(C[C@H](OC)C(=O)O)cc1

nearest known ligand 0.59

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 14/20 0.59
PPARG P37231 4/20 0.47
PPARA Q07869 4/20 0.47
PPARD Q03181 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3966859 1.00 TRPM8 (0.59) TRPM8PPARGPPARAPPARD
SCHEMBL3963766 0.81 TRPM8 (0.67) TRPM8PPARGPPARAPPARD
SCHEMBL5721440 0.81 TRPM8 (0.67) TRPM8PPARGPPARAPPARD
SCHEMBL5360551 0.80 PPARA (0.46) TRPM8PPARGPPARAPPARD
SCHEMBL3968262 0.80 TRPM8 (0.51) TRPM8PPARGPPARAPPARD
SCHEMBL5364382 0.80 TRPM8 (0.51) TRPM8PPARGPPARAPPARD
SCHEMBL3963064 0.79 PPARG (0.54) TRPM8PPARGPPARAPPARD
SCHEMBL3963060 0.79 PPARG (0.54) TRPM8PPARGPPARAPPARD
SCHEMBL5369727 0.79 TRPM8 (0.53) TRPM8PPARGPPARAPPARD
SCHEMBL3963767 0.79 TRPM8 (0.53) TRPM8PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7220880-B2 Amide linker peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (US) 2007-05-22 US disclosed
US-7220880-B2 Amide linker peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (US) 2007-05-22 US disclosed
US-7220880-B2 Amide linker peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (US) 2007-05-22 US disclosed
US-20060111406-A1 Amide linker peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (US) 2006-05-25 US disclosed
EP-1517882-A1 AMIDE LINKER PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2005-03-30 EP disclosed
WO-2004000789-A9 AMIDE LINKER PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS LILLY CO ELI (US) 2004-03-11 WO disclosed
WO-2004000789-A1 AMIDE LINKER PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2003-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060111406-A1 Amide linker peroxisome proliferator activated receptor modulators PPARG, PPARA, PPARD TRPM8 2269/4885PPARG 1/4885PPARA 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.